🇺🇸 FDA
Pipeline program

leuprorelin

XJTU1AF-CRF-2022-XK002

Unknown small_molecule active

Quick answer

leuprorelin for Hematopoietic Stem Cell Transplantation is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Hematopoietic Stem Cell Transplantation
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials